WiSys Technologies

12 WiSys Technologies in "Miscellaneous" or "Pharmaceuticals & Vitamin D"

Generation of Toxic Microparticles for Control of Invasive Species

WiSys is seeking a strategic partner for further optimization of the design for efficiency and manufacturing, followed by marketing, sales, and distribution.

Low Maintenance Snowmobile Ski Design that Increases Traction, Maneuverability and Safety on Paved Surfaces

WiSys is currently seeking a strategic partner interested in further developing and manufacturing this technology, ultimately providing a route to market for its commercialization. 

Improved wheelchair design utilizing linear rotary motion with enhanced efficiency and reduced injury and pain for users

WiSys is seeking a strategic partner in the Durable Medical Equipment industry interested in gaining a competitive edge in the marketplace.  WiSys' new and improved wheelchair design is the first application developed using the patented linear rotary motion platform technology and is available for exclusive licensing.  Additional fields of use are available for development and licensing.

Physics ‘Office Hours’ educational learning platform

WiSys Technology Foundation is seeking a commercial partner who is interested in licensing and distributing an educational app focused on Physics, expanding the platform beyond Android applications as well as further developing additional apps directed towards other STEM disciplines.

Saddle Lift to Enhance Independence of Horseback Riders with Disabilities

WiSys Technology Foundation is seeking a strategic partner for manufacturing, marketing, sales, and distribution of a lift that allows para-equestrian riders to independently saddle their horses.

Skin Whitening Agent(s)

WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.

Benzodiazepine Derivatives with Reduced Side Effects

The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.